Jay Rajadas-Drug development
LinkedInnewsletter · by Jay Rajadas
News about targeted drug development
- Audience
- Not shown publicly
- We show a dash rather than guess
- Observed frequency
- Monthly or less
- From 4 posts indexed in the last 90 days
- Last post
- Oct 18, 2026
- 24 days ago
- Likely audience
- neuroscientists
- Inferred from post content
Jay Rajadas-Drug development is a LinkedIn newsletter by Jay Rajadas covering protein homeostasis, neurodegeneration and molecular chaperones. NewsletterFIT indexed 4 posts from it in the last 90 days, most recently on Oct 18, 2026.
Topics
- protein homeostasis
- neurodegeneration
- molecular chaperones
- cardiovascular aging
- autophagy
Recent posts
- From the…
- The Architecture…
- Switching On…
- A Vision…
- Curious case…
Sponsors detected
No sponsored posts detected in the last 180 days of indexed posts.
Detected automatically from posts marked as sponsored. Detection can miss or misread placements.
See the full picture on Jay Rajadas-Drug development
Subscriber momentum over time, every detected sponsor with the source post, companies and people it mentions, guests, and an alert when any of it changes.
Jay Rajadas-Drug development alternatives: similar newsletters
Ranked by how many topics they share with Jay Rajadas-Drug development.
- Science Briefing158K subscribers
SubstackEvery two weeks · last post 41 days ago
Likely audience: Paramedics
1 shared topic
- balancedthyroid1K subscribers
SubstackEvery two weeks · last post 41 days ago
Likely audience: women with thyroid conditions
1 shared topic
Compiled from public pages · refreshed Nov 11, 2026 · How NewsletterFIT collects and labels data